Patent · US Active

Pyridocarbazole type compounds and applications thereof

US8604048B2 · kind B2 · utility

1Cited by

2References

16Claims

0Family size

Assignees

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
INSTITUT CURIE · FR
COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES · FR
Universite Paris SUD (Paris II) · FR

Inventors

Laurence Lafanechere · Grenoble, FR
Emilie Vassal · Crolles, FR
Caroline Barette · Grenoble, FR
ChiHung Nguyen · Antony, FR
Christian Rivalle · Palaiseau, FR
Renaud Prudent · Criel de Renage, FR

Key dates

Filing date	Feb 19, 2010
Grant date	Dec 10, 2013
Priority date	—
Expiry date	Feb 19, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pyridocarbazole-type compounds of formula (I):are provided as a medicament, and more particularly for application in anticancer chemotherapy. Also provided is a pharmaceutical composition with the compound and methods for preventing and/or treating neurodegenerative-type pathologies, such as Alzheimer's disease and schizophrenia, parasitoses, such as malaria, or glaucomas.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.